Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

515 ARTÍCULOS , VIENDO DEL 361 AL 375

The Great Debate in Diagnosing Alzheimer Disease: More Than Just a β Test

Villain N, Paretsky MS.

Neurology. 2024 Sep 10;103(5):e209836. doi: 10.1212/WNL.0000000000209836. Epub 2024 Aug 21.

Rationale and design of the BeyeOMARKER study: prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer's disease pathology in the eye clinic

Bader I, Groot C, Tan HS, Milongo JA, Haan JD, Verberk IMW, Yong K, Orellina J, Campbell S, Wilson D, van Harten AC, Kok PHB, van der Flier WM, Pijnenburg YAL, Barkhof F, van de Giessen E, Teunissen CE, Bouwman FH, Ossenkoppele R.

Alzheimers Res Ther. 2024 Aug 21;16(1):190. doi: 10.1186/s13195-024-01545-1.

Understanding the impact of slowing disease progression for individuals with biomarker-confirmed early symptomatic Alzheimer's disease

Desai U, Gomes DA, Chandler J, Ye W, Daly M, Kirson N, Dennehy EB.

Curr Med Res Opin. 2024 Oct;40(10):1719-1725. doi: 10.1080/03007995.2024.2394602. Epub 2024 Sep 1.

Updates in Alzheimer's disease: from basic research to diagnosis and therapies

Liu E, Zhang Y, Wang JZ.

Transl Neurodegener. 2024 Sep 4;13(1):45. doi: 10.1186/s40035-024-00432-x.

Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: an update of the literature

Milos T, Vuic B, Balic N, Farkas V, Nedic Erjavec G, Svob Strac D, Nikolac Perkovic M, Pivac N.

Expert Rev Neurother. 2024 Nov;24(11):1063-1079. doi: 10.1080/14737175.2024.2400683. Epub 2024 Sep 4.

CSF and blood glial fibrillary acidic protein for the diagnosis of Alzheimer's disease: A systematic review and meta-analysis

Zou Y, Wang Y, Ma X, Mu D, Zhong J, Ma C, Mao C, Yu S, Gao J, Qiu L.

Ageing Res Rev. 2024 Nov;101:102485. doi: 10.1016/j.arr.2024.102485. Epub 2024 Sep 4.

[Blood Biomarkers for Alzheimer's Disease: Current Status and Prospects]

Ikeuchi T.

Brain Nerve. 2024 Sep;76(9):1045-1052. doi: 10.11477/mf.1416202730.

Fluid biomarkers in the context of amyloid-targeting disease-modifying treatments in Alzheimer's disease

Hu Y, Cho M, Sachdev P, Dage J, Hendrix S, Hansson O, Bateman RJ, Hampel H.

Med. 2024 Oct 11;5(10):1206-1226. doi: 10.1016/j.medj.2024.08.004. Epub 2024 Sep 9.

Association between blood-based protein biomarkers and brain MRI in the Alzheimer's disease continuum: a systematic review

Mitolo M, Lombardi G, Manca R, Nacmias B, Venneri A.

J Neurol. 2024 Nov;271(11):7120-7140. doi: 10.1007/s00415-024-12674-w. Epub 2024 Sep 12.

[Chinese guideline for clinical application of fluid biomarkers for Alzheimer's disease(2024 edition)]

National Health Commission Capacity Building and Continuing Education Center; Chinese Neuroscience Society; Aging Biomarker Consortium; Writing Group for the Chinese Guideline for Clinical Application of Fluid Biomarkers for Alzheimer′s Disease.

Zhonghua Yi Xue Za Zhi. 2024 Sep 10;104(35):3292-3306. doi: 10.3760/cma.j.cn112137-20240523-01174.

Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer's disease

Collij LE, Mastenbroek SE, Mattsson-Carlgren N, Strandberg O, Smith R, Janelidze S, Palmqvist S, Ossenkoppele R, Hansson O.

Nat Commun. 2024 Sep 14;15(1):8061. doi: 10.1038/s41467-024-52299-1.

Prodromal Alzheimer's Disease: Global Cognition, Cue Efficiency, and Cerebrospinal Fluid Neurofilament Light Values Predict Short-Term Conversion to Dementia

Méndez-Barrio C, Medina-Rodríguez M, Mendoza-Vázquez G, García-Roldán E, Rodrigo-Herrero S, Luque-Tirado A, Almodóvar-Sierra Á, Franco-Macías E.

J Alzheimers Dis. 2024;101(3):877-887. doi: 10.3233/JAD-240689.

Plasma Biomarkers of Alzheimer's Disease and Neurodegeneration According to Sociodemographic Characteristics and Chronic Health Conditions

Zheng HT, Wu Z, Mielke MM, Murray AM, Ryan J.

J Prev Alzheimers Dis. 2024;11(5):1189-1197. doi: 10.14283/jpad.2024.142.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias